The ALLgorithMM: How to define the hemodilution of bone marrow samples in lymphoproliferative diseases

IntroductionMinimal residual disease (MRD) is commonly assessed in bone marrow (BM) aspirate. However, sample quality can impair the MRD measurement, leading to underestimated residual cells and to false negative results. To define a reliable and reproducible method for the assessment of BM hemodilu...

Szczegółowa specyfikacja

Opis bibliograficzny

Główni autorzy:	Ilaria Vigliotta, Silvia Armuzzi, Martina Barone, Vincenza Solli, Ignazia Pistis, Enrica Borsi, Barbara Taurisano, Gaia Mazzocchetti, Marina Martello, Andrea Poletti, Chiara Sartor, Ilaria Rizzello, Lucia Pantani, Paola Tacchetti, Cristina Papayannidis, Katia Mancuso, Serena Rocchi, Elena Zamagni, Antonio Curti, Mario Arpinati, Michele Cavo, Carolina Terragna
Format:	Artigo
Język:	Inglês
Wydane:	Frontiers Media S.A. 2022-10-01
Seria:	Frontiers in Oncology
Hasła przedmiotowe:	minimal residual disease multiple myeloma acute lymphoblastic leukemia hemodilution hemodilution/methods flow cytometry
Dostęp online:	https://www.frontiersin.org/articles/10.3389/fonc.2022.1001048/full
Etykiety:	Dodaj etykietę Nie ma etykietki, Dołącz pierwszą etykiete!